Prosecution Insights
Last updated: August 08, 2026

LifeCell Corporation

7 pending office actions • 4 art units • 5 examiners • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (29%)
4
Medium (57%)
1
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (14%)
Double-patenting only1 (14%)
Double-patenting + other3 (43%)
Multi-statute (no §101)2 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
29% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
29% of docket
3
Business / Other
43% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GHERBI, SUZETTE JAIME J 3 85.0% +8.7%
PALLAY, MICHAEL B 1 55.7% +34.7%
BARIA, DINAH N 1 73.3% +28.7%
PELLEGRINO, BRIAN E 1 55.2% +35.8%
SAEED, ALI S 1 31.2% +34.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18119753 BIOLOGIC BREAST IMPLANT GHERBI, SUZETTE JAIME J 71d
18783873 BREAST PROSTHESES, METHODS OF MANUFACTURING BREAST PROSTHESES, AND METHODS OF TREATMENT USING BREAST PROSTHESES GHERBI, SUZETTE JAIME J

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18613843 TISSUE PRODUCTS WITH VARIATIONS IN MECHANICAL PROPERTIES AND METHODS OF TREATMENT PELLEGRINO, BRIAN E 14d
18632995 ADIPOSE TISSUE MATRIX WITH TROPOELASTIN GHERBI, SUZETTE JAIME J

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18613843 TISSUE PRODUCTS WITH VARIATIONS IN MECHANICAL PROPERTIES AND METHODS OF TREATMENT PELLEGRINO, BRIAN E 14d
16894261 COATED POLYMERIC MATERIAL SAEED, ALI S 56d
18758456 ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION PALLAY, MICHAEL B
18641818 PERFORATED TISSUE MATRIX BARIA, DINAH N

Top Art Units

Art UnitApps
1617 1
3799 1
3774 1
1616 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18783873 BREAST PROSTHESES, METHODS OF MANUFACTURING BREAST PROSTHESES, AND METHODS OF TREATMENT USING BREAST PROSTHESES GHERBI, SUZETTE JAIME J DP Non-Final OA Pending Jul 25, 2024
18758456 ADIPOSE TISSUE PRODUCTS AND METHODS OF PRODUCTION PALLAY, MICHAEL B 1617 §103DP Non-Final OA Pending Jun 28, 2024
18641818 PERFORATED TISSUE MATRIX BARIA, DINAH N §103§112DP Non-Final OA Pending Apr 22, 2024
18632995 ADIPOSE TISSUE MATRIX WITH TROPOELASTIN GHERBI, SUZETTE JAIME J §102§103 Non-Final OA Pending Apr 11, 2024
18613843 TISSUE PRODUCTS WITH VARIATIONS IN MECHANICAL PROPERTIES AND METHODS OF TREATMENT PELLEGRINO, BRIAN E 3799 §103§112 Non-Final OA 14d Pending Mar 22, 2024
18119753 BIOLOGIC BREAST IMPLANT GHERBI, SUZETTE JAIME J 3774 §103§112DPOther Final Rejection 71d Pending Mar 09, 2023
16894261 COATED POLYMERIC MATERIAL SAEED, ALI S 1616 §103Other Final Rejection 56d Pending Jun 05, 2020

Managing LifeCell Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month